Soleus Capital Management, L.P.

Position in BMRN — Biomarin Pharmaceutical Inc

CIK 1802630 GREENWICH, CT

Position in BMRN

as of Jun 30, 2026 · filed Aug 11, 2026 Compact

Position Value

$21,490,229

-$15,260,583 QoQ

Shares Held

375,572

-42.3% QoQ

Ownership

0.194%

of shares outstanding

% of Portfolio

0.74%

of 13F equity value

Holder Rank

#75

of 561 holders

Holding Since

Jun 2023

8 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

Soleus Capital Management, L.P. holds $1,743,217,207 across 63 Biotechnology names. BMRN ranks #23 (1.2% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	KRYS	Krystal Biotech, Inc.	939,254	$349,092,534
2	CELC	Celcuity Inc.	1,704,318	$178,305,749
3	TGTX	Tg Therapeutics, Inc.	2,927,895	$160,858,551
4	RIGL	Rigel Pharmaceuticals Inc	1,843,504	$72,117,876
5	VCEL	Vericel Corp	1,459,152	$64,917,672
6	PRAX	Praxis Precision Medicines, Inc.	177,517	$59,430,916
7	GERN	Geron Corp	42,808,659	$54,795,083
8	ERAS	Erasca, Inc.	2,700,000	$49,464,000

8 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$21,490,229	375,572	-42.3%	Shares	Sole	2026-08-11
2026-03-31	$36,750,812	650,572	-50.7%	Shares	Sole	2026-05-14
2025-12-31	$78,447,600	1,320,000	+48.3%	Shares	Sole	2026-02-12
2025-09-30	$48,218,864	890,304	-1.3%	Shares	Sole	2025-11-14
2025-06-30	$49,599,650	902,304	-16.4%	Shares	Sole	2025-08-15
2025-03-31	$76,295,999	1,079,304	+7.8%	Shares	Sole	2025-05-15
2024-12-31	$65,822,022	1,001,400	+1632.5%	Shares	Sole	2025-02-14
2023-06-30	$5,010,104	57,800	—	Shares	Sole	2023-08-14
No filing history on record for this holder in this stock.